VEGFA and type 2 diabetes mellitus: To clarify the beneficial effect of tofogliflozin on the pathogenesis of DR, we performed immunohistochemical analysis to investigate whether the long-term systemic administration of SGLT2i ameliorates the glial activation and VEGF expression in the retina of the type 2 diabetic murine model.